{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:15:34Z","timestamp":1792685734546,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.jaad.2023.02.053","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T03:35:47Z","timestamp":1678851347000},"page":"316-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review"],"prefix":"10.1016","volume":"89","author":[{"given":"Susan","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Elbuluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearl","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Alexis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelani","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seemal R.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2023.02.053_bib1","first-page":"387","article-title":"Common dermatologic disorders in skin of color: a comparative practice survey","volume":"80","author":"Alexis","year":"2007","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.jaad.2023.02.053_bib2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2133.1999.03047.x","article-title":"A study of the spectrum of skin disease occurring in a black population in south-east London","volume":"141","author":"Child","year":"1999","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.02.053_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ijd.12589","article-title":"The spectrum of skin diseases in a black population in Durban, KwaZulu-Natal, South Africa","volume":"54","author":"Dlova","year":"2015","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib4","first-page":"388","article-title":"Incidence of common dermatoses in a predominantly black dermatologic practice","volume":"32","author":"Halder","year":"1983","journal-title":"Cutis"},{"issue":"suppl 5","key":"10.1016\/j.jaad.2023.02.053_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jdv.14374","article-title":"What is new in the pathophysiology of acne, an overview","volume":"31","author":"Dreno","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.jaad.2023.02.053_bib6","first-page":"20","article-title":"Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color","volume":"3","author":"Davis","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.02.053_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/1346-8138.13263","article-title":"Frequency and characteristics of acne-related post-inflammatory hyperpigmentation","volume":"43","author":"Abad-Casintahan","year":"2016","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.02.053_bib8","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/09546634.2018.1542807","article-title":"Survey of acne-related post-inflammatory hyperpigmentation in the Middle East","volume":"30","author":"Abanmi","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jaad.2023.02.053_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/09546630903401496","article-title":"Acne in skin of color: practical approaches to treatment","volume":"21","author":"Shah","year":"2010","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09546630802132635","article-title":"Clinical considerations on the use of concomitant therapy in the treatment of acne","volume":"19","author":"Alexis","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.jaad.2023.02.053_bib11","first-page":"1","article-title":"Topical agents used in the management of hyperpigmentation","volume":"9","author":"Halder","year":"2004","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jaad.2023.02.053_bib12","series-title":"Laser Fitzpatrick skin type recommendations","author":"Sharma","year":"2021"},{"issue":"7","key":"10.1016\/j.jaad.2023.02.053_bib13","first-page":"19","article-title":"Racial differences in clinical characteristics, perceptions and behaviors, and psychosocial impact of adult female acne","volume":"7","author":"Callender","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.02.053_bib14","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1067\/mjd.2002.120791","article-title":"Acne vulgaris in skin of color","volume":"46","author":"Taylor","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4103\/2229-5178.142486","article-title":"Misuse of topical corticosteroids: a clinical study of adverse effects","volume":"5","author":"Dey","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/15569520701555383","article-title":"Comedogenicity in rabbit: some cosmetic ingredients\/vehicles","volume":"26","author":"Nguyen","year":"2007","journal-title":"Cutan Ocul Toxicol"},{"issue":"3","key":"10.1016\/j.jaad.2023.02.053_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/DSS.0000000000002813","article-title":"Common dermatologic procedures and the associated complications unique to skin of color","volume":"47","author":"Adotama","year":"2021","journal-title":"Dermatol Surg"},{"issue":"suppl 3","key":"10.1016\/j.jaad.2023.02.053_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/bjd.12526","article-title":"Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI","volume":"169","author":"Alexis","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2023.02.053_bib19","first-page":"195","article-title":"An experimental application of the Delphi method to the use of experts","volume":"9","author":"Dalkey","year":"1963","journal-title":"Manag Sci"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib20","first-page":"33","article-title":"Concomitant therapy for acne in patients with skin of color: a case-based approach","volume":"21","author":"Alexis","year":"2009","journal-title":"Dermatol Nurs"},{"key":"10.1016\/j.jaad.2023.02.053_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-021-00643-2","article-title":"Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice","volume":"23","author":"Callender","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib22","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jaad.2019.05.078","article-title":"Efficacy and safety of a novel topical minocycline foam for the treatment of moderate to severe acne vulgaris: a phase 3 study","volume":"82","author":"Raoof","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.02.053_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.02.053_bib24","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2023.02.053_bib25","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/jdv.13776","article-title":"European evidence-based (S3) guideline for the treatment of acne\u2014update 2016\u2014short version","volume":"30","author":"Nast","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"20","key":"10.1016\/j.jaad.2023.02.053_bib26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJM199305203282002","article-title":"Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients","volume":"328","author":"Bulengo-Ransby","year":"1993","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib27","first-page":"45","article-title":"Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study","volume":"77","author":"Grimes","year":"2006","journal-title":"Cutis"},{"issue":"7","key":"10.1016\/j.jaad.2023.02.053_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.36849\/JDD.2020.5125","article-title":"Novel polymeric tazarotene 0.045% lotion for moderate-to-severe acne: pooled phase 3 analysis by race\/ethnicity","volume":"19","author":"Bhatia","year":"2020","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2023.02.053_bib29","first-page":"1107","article-title":"Treatment of moderate acne vulgaris in Fitzpatrick skin type V or VI: efficacy and tolerability of fixed combination clindamycin phosphate 1.2%\/benzoyl peroxide 3.75% gel","volume":"17","author":"Amar","year":"2018","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2023.02.053_bib30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/ijd.14948","article-title":"Efficacy and safety of Jessner's solution peel in comparison with salicylic acid 30% peel in the management of patients with acne vulgaris and postacne hyperpigmentation with skin of color: a randomized, double-blinded, split-face, controlled trial","volume":"59","author":"How","year":"2020","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.02.053_bib31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1529-8019.2006.00085.x","article-title":"Retinoid therapy of pigmentary disorders","volume":"19","author":"Ortonne","year":"2006","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0190-9622(86)70236-3","article-title":"Epidermal effects of retinoids: supramolecular observations and clinical implications","volume":"15","author":"Elias","year":"1986","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2023.02.053_bib33","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/S0923-1811(01)00116-5","article-title":"Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes","volume":"27","author":"Yoshimura","year":"2001","journal-title":"J Dermatol Sci"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib34","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1242\/jcs.107.4.1095","article-title":"Retinoic acid as modulator of UVB-induced melanocyte differentiation. Involvement of the melanogenic enzymes expression","volume":"107","author":"Romero","year":"1994","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.0022-202x.2001.01614.x","article-title":"All-trans retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor","volume":"118","author":"Watabe","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2023.02.053_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00128071-200910040-00005","article-title":"The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review","volume":"10","author":"Kang","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib37","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archderm.1975.01630130042004","article-title":"A new formula for depigmenting human skin","volume":"111","author":"Kligman","year":"1975","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2310\/7750.2009.08077","article-title":"Postinflammatory hyperpigmentation","volume":"13","author":"Taylor","year":"2009","journal-title":"J Cutan Med Surg"},{"issue":"11","key":"10.1016\/j.jaad.2023.02.053_bib39","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1111\/jocd.13725","article-title":"Efficacy and tolerability of chemical peeling as a single agent for melasma in dark-skinned patients: a systematic review and meta-analysis of comparative trials","volume":"19","author":"Dorgham","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2023.02.053_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fmed.2021.617068","article-title":"Professional-grade TCA-lactic acid chemical peel: elucidating mode of action to treat photoaging and hyperpigmentation","volume":"8","author":"Bhardwaj","year":"2021","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.jaad.2023.02.053_bib41","first-page":"442","article-title":"Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-gamma agonist trifarotene","volume":"179","author":"Aubert","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1524-4725.1999.08145.x","article-title":"The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups","volume":"25","author":"Grimes","year":"1999","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2023.02.053_bib43","first-page":"372","article-title":"Whitening effect of salicylic acid peels in Asian patients","volume":"32","author":"Ahn","year":"2006","journal-title":"Dermatol Surg"},{"issue":"3","key":"10.1016\/j.jaad.2023.02.053_bib44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/JCAS.JCAS_135_18","article-title":"Comparative study of 35% glycolic acid, 20% salicylic-10% mandelic acid, and phytic acid combination peels in the treatment of active acne and postacne pigmentation","volume":"12","author":"Sarkar","year":"2019","journal-title":"J Cutan Aesthet Surg"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/DSS.0000000000001007","article-title":"Treatment of postinflammatory hyperpigmentation with a combination of glycolic acid peels and a topical regimen in dark-skinned patients: a comparative study","volume":"43","author":"Sarkar","year":"2017","journal-title":"Dermatol Surg"},{"issue":"11","key":"10.1016\/j.jaad.2023.02.053_bib46","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1111\/jocd.14502","article-title":"Safety and efficacy of microneedling technology in the treatment of acne scars","volume":"20","author":"Casabona","year":"2021","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/lsm.23173","article-title":"Treatment of post-inflammatory hyperpigmentation in patients with darker skin types using a low energy 1,927 nm non-ablative fractional laser: a retrospective photographic review analysis","volume":"52","author":"Bae","year":"2020","journal-title":"Lasers Surg Med"},{"issue":"4","key":"10.1016\/j.jaad.2023.02.053_bib48","first-page":"s135","article-title":"Laser treatment of skin of color for medical and aesthetic uses w ith a new 650-microsecond Nd:YAG 1064nm laser","volume":"18","author":"Roberts","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2023.02.053_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13941","article-title":"A randomized split-face, investigator-blinded study of a picosecond Alexandrite laser for post-inflammatory erythema and acne scars","volume":"33","author":"Wen","year":"2020","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14756366.2018.1545767","article-title":"A comprehensive review on tyrosinase inhibitors","volume":"34","author":"Zolghadri","year":"2019","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0974-2077.110089","article-title":"Cosmeceuticals for hyperpigmentation: what is available?","volume":"6","author":"Sarkar","year":"2013","journal-title":"J Cutan Aesthet Surg"},{"issue":"6","key":"10.1016\/j.jaad.2023.02.053_bib52","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4103\/0019-5154.169122","article-title":"Exogenous ochronosis","volume":"60","author":"Bhattar","year":"2015","journal-title":"Indian J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.02.053_bib53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1529-8019.2007.00144.x","article-title":"Skin lightening preparations and the hydroquinone controversy","volume":"20","author":"Draelos","year":"2007","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.jaad.2023.02.053_bib54","first-page":"586","article-title":"Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study","volume":"10","author":"Kircik","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2023.02.053_bib55","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1524-4725.1996.tb00345.x","article-title":"The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2023.02.053_bib56","unstructured":"Tawfic SO, Abdel Hay R, Salim H, Elmasry MF. Tranexamic acid versus fractional carbon dioxide laser in post-acne hyperpigmentation. Dermatol Ther. 202134(6):e15103."},{"issue":"suppl 4","key":"10.1016\/j.jaad.2023.02.053_bib57","first-page":"48","article-title":"Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients","volume":"68","author":"Jacyk","year":"2001","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib58","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/jidsymp.2008.7","article-title":"Latest insights into skin hyperpigmentation","volume":"13","author":"Ortonne","year":"2008","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"suppl 8","key":"10.1016\/j.jaad.2023.02.053_bib59","first-page":"s109","article-title":"The sequence of inflammation, relevant biomarkers, and the pathogenesis of acne vulgaris: what does recent research show and what does it mean to the clinician?","volume":"12","author":"Del Rosso","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2023.02.053_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1046\/j.1523-1747.2003.12321.x","article-title":"Inflammatory events are involved in acne lesion initiation","volume":"121","author":"Jeremy","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2023.02.053_bib61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1346-8138.2006.00174.x","article-title":"Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris","volume":"33","author":"Matsuoka","year":"2006","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2023.02.053_bib62","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijwd.2020.10.008","article-title":"Sunscreen recommendations for patients with skin of color in the popular press and in the dermatology clinic","volume":"7","author":"Song","year":"2021","journal-title":"Int J Women\u2019s Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223003663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223003663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:24:42Z","timestamp":1759274682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223003663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0190962223003663"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.02.053","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment recommendations for acne-associated hyperpigmentation: Results of the Delphi consensus process and a literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.02.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}